file-photo-people-riding-a-motorcycle-in-front-of-the-office-of-ranbaxy-laboratories-at-gurgaon

Ranbaxy Posts Loss after Write-offs on U.S. Import Bans

Drugmaker Ranbaxy Laboratories Ltd (RANB.NS), which has agreed to be acquired by Sun Pharmaceutical Industries Ltd (SUN.NS) for $3.2 billion, posted a loss in the March quarter, hit by write-offs related to regulatory sanctions. May 10, 2014